KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Equity (2016 - 2025)

Pacira BioSciences (PCRX) has 15 years of Return on Equity data on record, last reported at 0.01% in Q4 2025.

  • For Q4 2025, Return on Equity rose 14.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 14.0%, while the annual FY2025 figure was 0.01%, 13.0% up from the prior year.
  • Return on Equity reached 0.01% in Q4 2025 per PCRX's latest filing, down from 0.03% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.26% in Q2 2021 and bottomed at 0.16% in Q2 2025.
  • Average Return on Equity over 5 years is 0.02%, with a median of 0.03% recorded in 2022.
  • Peak YoY movement for Return on Equity: grew 29bps in 2021, then dropped -24bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.06% in 2021, then plummeted by -64bps to 0.02% in 2022, then skyrocketed by 139bps to 0.05% in 2023, then crashed by -364bps to 0.13% in 2024, then skyrocketed by 108bps to 0.01% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.01% in Q4 2025, 0.03% in Q3 2025, and 0.16% in Q2 2025.